Tango Therapeutics, Inc.TNGXNASDAQ
LOADING
|||
Key Metrics
As of 2024• vs 2023
Per Share
Revenue/Share
$0.39-0.3%
Net Income/Share
$-1.19-10.9%
Operating CF/Share
$-1.20+3.5%
Free CF/Share
$-1.21+4.2%
Cash/Share
$2.36-33.7%
Book Value/Share
$1.83-31.7%
Tangible Book/Share
$1.83-31.7%
Equity/Share
$1.83-31.7%
Interest Debt/Share
$0.33-18.8%
Valuation
Market Cap
$337.51M-64.0%
Enterprise Value
P/E Ratio$304.47M-66.5%
-2.59+71.9%
P/S Ratio8.02-68.7%
P/OCF Ratio
-2.57+67.7%
P/FCF Ratio
P/B Ratio-2.55+67.4%
1.69-54.3%
P/TB Ratio
EV/Sales1.69-54.3%
7.24-70.9%
EV/EBITDA
-2.13+73.8%
Profitability
Earnings Yield-38.61%-255.3%
FCF Yield-39.19%-207.0%
ROE-65.31%-62.5%
ROIC-51.85%-62.9%
Return on Tangible Assets-41.17%-62.9%
Capital Allocation
CapEx/OCF
-0.57%+55.7%
CapEx/Revenue
1.79%-57.1%
CapEx/Depreciation
0.30-52.3%
SBC/Revenue
68.69%+31.5%
Balance Sheet
Debt/Equity0.18+18.9%
Debt/Assets0.12+19.3%
Net Debt/EBITDA
Current Ratio0.23-6.1%
6.98-7.5%
Interest Coverage0.00x
Income Quality1.01-13.0%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$1.29-34.9%